Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,194 | -4,175 | -22,103 | -17,410 | -11,157 |
| Depreciation Amortization | 1,099 | 498 | 1,198 | 918 | 576 |
| Accounts receivable | -1,545 | -1,202 | -2,068 | -9 | -170 |
| Accounts payable and accrued liabilities | -310 | 129 | 728 | 907 | 369 |
| Other Working Capital | -4,745 | -3,556 | 2,816 | 1,982 | 1,561 |
| Other Operating Activity | 4,367 | 2,202 | 3,186 | 1,129 | 76 |
| Operating Cash Flow | $-13,328 | $-6,104 | $-16,243 | $-12,483 | $-8,745 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,956 | -11,848 | 4,000 | 4,000 | 5,000 |
| PPE Investments | -2,168 | -1,003 | -3,476 | -2,919 | -1,529 |
| Purchase Sale Intangibles | -345 | -345 | -1,327 | -1,306 | -739 |
| Other Investing Activity | 155 | -96 | -2,670 | -4,900 | -739 |
| Investing Cash Flow | $-18,969 | $-12,947 | $-2,146 | $-3,819 | $2,732 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 166 | N/A | 991 | 835 | N/A |
| Debt Repayment | -561 | -287 | -1,984 | -1,608 | -521 |
| Common Stock Issued | 278 | 105 | 48,523 | 48,352 | 48,352 |
| Other Financing Activity | 0 | 0 | -3,211 | -3,226 | -2,919 |
| Financing Cash Flow | $-117 | $-182 | $44,319 | $44,353 | $44,912 |
| Beginning Cash Position | 51,250 | 51,250 | 25,320 | 25,320 | 25,320 |
| End Cash Position | 18,836 | 32,017 | 51,250 | 53,371 | 64,219 |
| Net Cash Flow | $-32,414 | $-19,233 | $25,930 | $28,051 | $38,899 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,328 | -6,104 | -16,243 | -12,483 | -8,745 |
| Capital Expenditure | -2,168 | -1,003 | -3,476 | -2,919 | -1,529 |
| Free Cash Flow | -15,496 | -7,107 | -19,719 | -15,402 | -10,274 |